From Generics to Genius: India’s Pharma Awakens to Global Leadership

At the 17th Annual Healthcare Leadership Summit & Pharma Leaders Power Brand Awards 2026, Dr. Satya Brahma calls for a bold transformation—urging Indian pharma to move beyond generics and embrace innovation, trust, and accessibility as the pillars of global leadership.

The 17th Annual Healthcare Leadership Summit & Pharma Leaders Power Brand Awards 2026 set the stage for a defining debate in India’s healthcare journey. With the theme “From Generics to Genius: Reimagining Indian Pharma for Global Leadership in Innovation, Trust, and Accessibility,” the summit spotlighted India’s transition from being the “pharmacy of the world” to becoming a true innovation hub.

Dr. Satya Brahma, Founder Chairman of Network 7 Media Group and architect of the India Leadership Conclave, delivered a keynote that challenged the industry to rise above its comfort zone of generics. He emphasized that India’s pharmaceutical sector must not only supply affordable medicines but also pioneer breakthrough therapies, biosimilars, and digital health solutions that resonate globally.

India’s Dual Identity: The “pharmacy of the world” supplying 20% of global generics, yet still striving to break into high-value innovation.

• The Inflection Point: With India’s $30–35 trillion economic ambition by 2047, pharma must evolve from volume-driven generics to biosimilars, breakthrough therapies, and digital health ecosystems.
• Trust & Governance: Building credibility through transparent regulation, ethical clinical practices, and global competitiveness.
• Healthcare Equity: Ensuring that innovation does not widen the accessibility gap—making advanced therapies affordable for 1.5 billion Indians.
• Leadership Call: Positioning Indian pharma not just as a supplier, but as a strategic disruptor shaping global health narratives.

The urgency therefore is of aligning policy reforms, ethical governance, and patient-centric innovation with India’s ambition to become a $30–35 trillion economy by 2047. Innovation, Trust, Accessibility: The New Triad for India’s Pharma Leadership.

Dr. Satya Brahma says “India has been the medicine chest of the world. Now it must become the world’s innovation lab—where trust, transparency, and accessibility define our leadership. The time has come to move from generics to genius.”